Topical Sodium Thiosulfate Application for Calcinosis
Apply 25% w/v sodium thiosulfate topically to the affected calcinosis lesions once or twice daily, with treatment duration of at least 6 months to assess efficacy.
Application Protocol
Based on the available evidence, here is the practical approach:
Preparation and Application
- Concentration: Use 25% sodium thiosulfate solution, which can be compounded in zinc oxide base 1, 2
- Frequency: Apply once to twice daily directly to calcinosis lesions
- Duration: Continue treatment for a minimum of 6 months before assessing radiographic response 1
- Coverage: Apply directly to the calcified areas and surrounding skin
Expected Outcomes and Response Rates
The evidence shows variable but meaningful responses:
- Pediatric patients respond better than adults (54.5% vs 17.6% response rate, p=0.035) 1
- Overall clinical effectiveness in approximately 32% of patients with ectopic calcifications 1
- Some patients achieve complete disappearance of calcifications 1
- Excellent response reported in ulcerative calcinosis cutis cases 2
Important Clinical Considerations
Patient Selection: Topical sodium thiosulfate appears most effective for:
- Pediatric calcinosis (significantly better response) 1
- Dystrophic calcinosis cutis associated with dermatomyositis, systemic sclerosis, or other connective tissue diseases 1, 2
- Ulcerative calcinosis lesions 2, 3
Monitoring:
- Assess clinical response at regular intervals
- Obtain imaging (radiography or CT) after at least 6 months of treatment to document objective changes 1
- The treatment is well-tolerated with minimal adverse effects 1, 2, 3
Evidence Quality and Limitations
The 2025 EULAR guidelines acknowledge that evidence for calcinosis treatment is limited, with studies hampered by retrospective design, small sample sizes, lack of control groups, and absence of standardized assessment methods 4. However, topical sodium thiosulfate has emerged as a reasonable option given its safety profile and documented responses in case series.
The most robust data comes from the CATSS-O registry study 1, which analyzed 35 patients with complete data, showing statistically significant better response in children and good tolerability. Multiple case reports support its efficacy in ulcerative lesions 2, 3.
Common Pitfalls to Avoid
- Premature discontinuation: Response may take 6+ months; don't abandon treatment too early
- Inadequate coverage: Ensure the preparation reaches the calcified tissue
- Wrong formulation: The FDA-labeled sodium thiosulfate is for intravenous use as a cyanide antidote 5; topical formulations must be specially compounded at 25% concentration